MedPath
NMPA Approval

Peramivir Injection

国药准字H20244196

September 10, 2024

Drug Information

帕拉米韦注射液

注射剂

15ml:0.15g(按C₁₅H₂₈N₄O₄计)

化学药品

September 10, 2024

Company Information

Applicant Company

武汉市东湖新技术开发区高新大道666号人福医药集团C7栋216室

Manufacturing Company

湖北省武汉市东湖新技术开发区光谷生物园神墩二路98号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

帕拉米韦注射液 - NMPA 批准文号 | MedPath